<DOC>
	<DOCNO>NCT02422875</DOCNO>
	<brief_summary>The purpose study compare immune phenotype , function , specificity B lymphocytes different developmental stage autoimmune patient B cell infectious disease patient healthy control .</brief_summary>
	<brief_title>Comparative Autoantibody Immunologic Cell Marker Study</brief_title>
	<detailed_description>It essential analyze distribution autoreactive B cell within bone marrow order study immature B cell developmental subset , present peripheral blood . Lymphocyte subsets bone marrow characterize described peripheral blood .</detailed_description>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Signed write informed consent subject , subject unable provide inform consent , subject 's legal representative may provide consent . Subjects either gender Subjects autoimmune disease , Systemic Lupus Erythematosus ( SLE ) patient fulfill American College Rheumatology Classification criterion SLE determine treat physician may incomplete criterion ( &lt; 4 item ) . SLE patient restrict treatment disease activity determine Systemic Lupus Erythematosus Disease Activity Index ( SLEDAI ) Systemic Lupus Activity Measure ( SLAM ) score 1 . Subjects acute exacerbation disease , include hospitalize patient 2 . Firstdegree relative subject active disease Subjects receive receive vaccination may enrol bone marrow aspirate and/or vaccination . Vaccination do subject 's healthcare provider another outside source . Subjects may screen blood draw perform case certain subset cell antibody titer desire . This may follow additional blood draw and/or bone marrow aspiration ideal candidate identify . Subjects diagnose HIV another infectious disease Healthy control must free acute chronic disease time bone marrow donation Poor venous access Subjects side effect local anesthetic Lidocaine blood thinner warfarin Normal control must free acute chronic disease medication may affect assay ( determined investigator ) . Insufficient access iliac crest bone hinder . This generally correlate BMI ( Body Mass Index ) great 25.0 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Sj√∂gren 's Syndrome</keyword>
	<keyword>Scleroderma</keyword>
	<keyword>Myositis</keyword>
	<keyword>Juvenile Idiopathic Arthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Inflammatory Arthritis</keyword>
	<keyword>Undifferentiated Connective Tissue Disease</keyword>
	<keyword>Idiopathic thrombocytopenic purpura</keyword>
	<keyword>Graft v Host Disease</keyword>
	<keyword>Autoimmune Lymphoproliferative Syndrome</keyword>
	<keyword>Immunoglobulin G4 ( IgG4 ) -related disease</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Epstein Barr Virus ( infectious mononucleosis - EBV )</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Guillain-Barre syndrome</keyword>
	<keyword>Mycoplasma pneumoniae</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
</DOC>